ORIC PHARMACEUTICALS INC (ORIC) Stock Income Statement
NASDAQ:ORIC - US68622P1093 - Common Stock
10.6 USD
+0.22 (+2.12%)
10.6 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 150.00M | 143.00M | 111.00M | 91.77M | 78.87M | |||
| Research and Development | 118.36M | 114.07M | 85.17M | 66.68M | 56.86M | |||
| Selling, General, and Administrative Expenses | 31.32M | 29.00M | 26.00M | 25.09M | 22.01M | |||
| Operating Income | -150.00M | -143.00M | -111.00M | -91.77M | -78.87M | |||
| Interest Income/Expense | 12.42M | 15.05M | 10.08M | 2.65M | 140.00K | |||
| Other Income/Expense | N/A | N/A | N/A | 0.00 | 20.00K | |||
| Non Recurring Items | N/A | N/A | 0.00 | N/A | 0.00 | |||
| Income Before Taxes | -137.00M | -128.00M | -101.00M | -89.12M | -78.72M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -137.00M | -128.00M | -101.00M | -89.12M | -78.72M | |||
| EBITDA | -148.81M | -141.89M | -109.97M | -90.80M | -77.97M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.89 | -1.83 | -1.98 | -2.25 | -2.07 | |||
| Non GAAP EPS | -1.89 | -1.82 | -1.96 | -2.25 | -2.07 | |||
| Statistics | ||||||||
All data in USD